Delivery Order SPE2DB24D3013-SPE2DB25FFQRK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,755.64 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract. The order, valued at $2,400.59, represents a competitive award with no set-aside designation and a completion deadline of July 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $1,649.05. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen will perform this contract from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) with a contract ceiling value of $5,993.70. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The ultimate completion date is set for July 23, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,221.69 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Qulipta 30 mg tablets (30-count). The contract utilizes firm fixed-price pricing with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,471.33 to supply Qulipta 60 mg tablets (30-count packages) for delivery to the company's Conshohocken, Pennsylvania headquarters. This competitively awarded, firm fixed-price contract was executed on June 17, 2025, with an ultimate completion date of June 18, 2025, and carries no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,309.58 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQRKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,036.88 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and distribution operations. This delivery order is one of numerous orders placed against AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a diverse range of medications, vaccines, and medical supplies to support Department of Defense healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, and related medical commodities. The award reflects the company's established capability to fulfill federal medical supply requirements and its significant role in supporting military healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/17/25 |